Loss of synovial tissue macrophage homeostasis precedes rheumatoid arthritis clinical onset
Megan M. Hanlon, Conor M. Smith, Mary Canavan, Nuno Neto, Qingxuan Song, Myles Lewis, Aoife M. O’Rourke, Orla Tynan, Brianne E. Barker, Phil Gallagher, Ronan Mullan, Conor Hurson, Barry Moran, Michael G. Monaghan, Costantino Pitzalis, Jean M. Fletcher, Sunil Nagpal, Douglas J. Veale, Ursula Fearon
Abstract
This study performed an in-depth investigation into the myeloid cellular landscape in the synovium of patients with rheumatoid arthritis (RA), “individuals at risk” of RA, and healthy controls (HC). Flow cytometric analysis demonstrated the presence of a CD40-expressing CD206 + CD163 + macrophage population dominating the inflamed RA synovium, associated with disease activity and treatment response. In-depth RNA sequencing and metabolic analysis demonstrated that this macrophage population is transcriptionally distinct, displaying unique inflammatory and tissue-resident gene signatures, has a stable bioenergetic profile, and regulates stromal cell responses. Single-cell RNA sequencing profiling of 67,908 RA and HC synovial tissue cells identified nine transcriptionally distinct macrophage clusters. IL-1B + CCL20 + and SPP1 + MT2A + are the principal macrophage clusters in RA synovium, displaying heightened CD40 gene expression, capable of shaping stromal cell responses, and are importantly enriched before disease onset. Combined, these findings identify the presence of an early pathogenic myeloid signature that shapes the RA joint microenvironment and represents a unique opportunity for early diagnosis and therapeutic intervention.